Search Results - "atrial fibrillation"

This review is focused on the role of latent inflammation in atrial fibrillation (AF) pathogenesis. The modern views and available evidence on the association between the levels of inflammatory markers and AF development and recurrence are presented. The justification for the use of pleiotropic effe...

Full description

Aim. To identify the predictors of paroxysmal thyrotoxic atrial fibrillation (AF). Material and methods. The study included 68 patients with AF and thyrotoxicosis. All participants were divided into two groups: Group I (n=51) included patients with paroxysmal AF (mean age 54±8,7 years; 41% men); Gro...

Full description

Aim. To study the change of local myocardial contractility in patients with ischemic heart disease (IHD) and paroxysmal atrial fibrillation (AF) during treatment with amiodarone 200 mg daily compared with bisoprolol therapy 5 mg daily.Material and methods. A total of 47 IHD patients with persistent...

Full description

Inhibitors of the renin-angiotensin-aldosterone system, statins, and possibly , ω-3 polyunsaturated fatty acids may influence the incidence of atrial fibrillation (AF), and can be used to prevent it. In recent medical literature, this approach is referred to as upstream treatment. The results of exp...

Full description

Aim: to study the association of rs2200733 polymorphism with antiarrhythmic efficacy of amiodarone, propafenone and allapinin in the prevention of atrial fibrillation (AF) progression.Material and methods. In order to comparatively evaluate the effectiveness of antiarrhythmic drugs in the prevention...

Full description

In article, we studied the heart biomechanics and main arteries kinetics in different types of atrial fibrillation. We described the increase of main hemodynamic parameters in atrial fibrillation. We created the functional classification of atrial fibrillation based on the maximum duration of pauses...

Full description

Background:Atrial fibrillation (AF) is the most common cardiac arrhythmia, affecting millions worldwide. While moderate physical activity is known to reduce AF risk, endurance athletes, particularly males, appear to have a higher prevalence of AF. The relationship between physical activity and AF f...

Full description

Atrial fibrillation is a serious adverse reaction associated with the use of anticancer drugs. The aim of the study was to analyse scientific literature on the prevalence, pathophysiological mechanisms, and risk factors of anticancer drug-induced atrial fibrillation, ways of its prevention and treat...

Full description

Background: Postoperative atrial fibrillation (POAF) is common after cardiac surgery and related to endothelial activation and systemic inflammation. Herein, we investigate the pathophysiological mechanisms of AF through endothelial activation and cell-cell interactions related to the development of...

Full description

Introduction: The Atrial Fibrillation Better Care (ABC) pathway was introduced to improve the management of patients with atrial fibrillation (AF) thus improving their outcomes. However, adherence to the ABC pathway has been found to be suboptimal in many studies. Objective: To investigate the preva...

Full description

Aim. To evaluate the usefulness of atrial fibrillation (AF) risk predictors for assessment for long-term and short-term risk of its development in patients with metabolic syndrome (MS) during prospective study.Material and methods. During 1998-2008 y. we studied 1968 patients with MS at the age of 4...

Full description

Background Incident atrial fibrillation (AF) is common among adults with kidney failure treated with maintenance dialysis and is associated with poor clinical outcomes. Limited data exist informing treatment of AF among patients on dialysis. We aimed to describe the use of rate‐control and antiarrhy...

Full description

Aim. To evaluate the prevalence of oral anticoagulant therapy at the outpatient and inpatient stages in patients hospitalized with ischemic stroke.Material and methods. This open observational prospective real-world study included 114 patients with atrial fibrillation (AF) hospitalized with confirme...

Full description

The review discusses the problem of anticoagulant therapy for the prevention of stroke and systemic embolism in patients with atrial fibrillation and comorbidities (hypertension, heart defects, including after heart valve surgery, coronary artery disease, diabetes mellitus, chronic kidney disease, g...

Full description

Adequate primary and secondary prevention of thromboembolic complications is one of the main goals of management of patients with atrial fibrillation. Many years of practice and experience of warfarin use, unfortunately, did not lead to wider and more efficient use of anticoagulation therapy. New or...

Full description

Adequate primary and secondary prevention of thromboembolic complications is one of the main goals of management of patients with atrial fibrillation. Many years of practice and experience of warfarin use, unfortunately, did not lead to wider and more efficient use of anticoagulation therapy. New or...

Full description

Aim. To study the effect of rivaroxaban compared with warfarin on the incidence of cardioembolic stroke and systemic thromboembolic complications (TEC), bleeding in patients with non-valvular atrial fibrillation (AF).Material and methods. Patients (n=126) older than 18 years, appealed to the Cardiol...

Full description

The problem of antiplatelet drug choice in patients with atrial fibrillation is discussed. Authors give special attention to new alternative drugs for prevention of thrombotic complications apart from old known antiplatelet drugs.

In a placebo-controlled study, propafenone efficacy and safety for pharmaceutical cardioversion in atrial fibrillation (AF) paroxysms were studied. The study included 50 patients aged 28-69 years (mean age 53,9+9,7), with AF paroxysms lasting for less than 48 hours. Participants were randomized to p...

Full description